2nd Quarter - Report
THE KPM GROUP DC LLC for OVID THERAPEUTICS
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 2938, the Bipartisan Safer Communities Act H.R. 7667, the Food and Drug Amendments of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.